Zenas BioPharma (ZBIO) Leases (2023 - 2025)
Zenas BioPharma (ZBIO) has 3 years of Leases data on record, last reported at $807000.0 in Q3 2025.
- For Q3 2025, Leases rose 102.26% year-over-year to $807000.0; the TTM value through Sep 2025 reached $807000.0, up 102.26%, while the annual FY2024 figure was $1.0 million, 22.29% up from the prior year.
- Leases reached $807000.0 in Q3 2025 per ZBIO's latest filing, down from $1.0 million in the prior quarter.
- Across five years, Leases topped out at $1.2 million in Q1 2025 and bottomed at $399000.0 in Q3 2024.
- Average Leases over 3 years is $874166.7, with a median of $912500.0 recorded in 2023.
- Peak YoY movement for Leases: rose 22.29% in 2024, then skyrocketed 102.26% in 2025.
- A 3-year view of Leases shows it stood at $821000.0 in 2023, then grew by 22.29% to $1.0 million in 2024, then decreased by 19.62% to $807000.0 in 2025.
- Per Business Quant database, its latest 3 readings for Leases were $807000.0 in Q3 2025, $1.0 million in Q2 2025, and $1.2 million in Q1 2025.